Search by Drug Name or NDC

    NDC 50742-0646-05 Triazolam 0.25 mg/1 Details

    Triazolam 0.25 mg/1

    Triazolam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ingenus Pharmaceuticals, LLC. The primary component is TRIAZOLAM.

    Product Information

    NDC 50742-0646
    Product ID 50742-646_22a3bdbc-8edf-45a5-ad5c-4a0c3f73f255
    Associated GPIs 60201040000310
    GCN Sequence Number 003694
    GCN Sequence Number Description triazolam TABLET 0.25 MG ORAL
    HIC3 H21
    HIC3 Description SEDATIVE-HYPNOTICS - BENZODIAZEPINES
    GCN 14280
    HICL Sequence Number 001594
    HICL Sequence Number Description TRIAZOLAM
    Brand/Generic Generic
    Proprietary Name Triazolam
    Proprietary Name Suffix n/a
    Non-Proprietary Name Triazolam
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 0.25
    Active Ingredient Units mg/1
    Substance Name TRIAZOLAM
    Labeler Name Ingenus Pharmaceuticals, LLC
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA214219
    Listing Certified Through 2024-12-31

    Package

    NDC 50742-0646-05 (50742064605)

    NDC Package Code 50742-646-05
    Billing NDC 50742064605
    Package 500 TABLET in 1 BOTTLE, PLASTIC (50742-646-05)
    Marketing Start Date 2020-10-20
    NDC Exclude Flag N
    Pricing Information N/A